Growing reliance on China’s pharmaceutical supply chain is raising concerns among US policymakers, who warn that dependence on foreign sources for critical drug ingredients could pose long term risks to healthcare security. Lawmakers are increasingly focused on how China has expanded its role
AstraZeneca is deepening its presence in China’s fast growing biotech sector with plans to build a new cell therapy facility in Shanghai, reinforcing its long term commitment to advanced medical innovation in the region. The investment forms part of a broader expansion strategy
China’s manufacturing sector is advancing into a more automation driven phase in 2026 as industrial robotics density continues to rise across key production hubs. The growing number of robots deployed per worker reflects a structural shift toward intelligent manufacturing systems that prioritize efficiency,
China’s contract drug manufacturing industry is facing growing uncertainty as United States pharmaceutical companies accelerate efforts to bring production back onshore and restructure global supply chains. The shift reflects broader geopolitical tensions and strategic concerns around dependency on overseas manufacturing, particularly in critical
China’s robotics sector is entering a new phase in 2026 as research into humanoid robots begins moving from laboratory experimentation toward industrial applications. Robotics companies, technology startups, and manufacturing enterprises are investing heavily in next generation robotic systems designed to perform tasks previously
Researchers in China have developed an experimental technique that could significantly extend how long organs remain viable for transplantation, potentially reshaping the global organ transplant system. According to a peer reviewed study published in the Journal of Medical Devices, the method allows organs
China has approved its first implantable brain computer interface system, marking a major step in the country’s expanding neurotechnology sector. The device was developed by Neuracle Medical Technology and is designed to help patients with spinal cord injuries regain control of hand movements.
China’s manufacturing sector is witnessing a significant rise in industrial robotics deployment in 2026 as factories across the country expand investments in smart manufacturing technologies. Industrial automation has become a central pillar of China’s economic modernization strategy, with robotics systems now widely integrated
US pharmaceutical giant Eli Lilly has announced plans to invest an additional 3 billion US dollars in China over the next decade, reinforcing its long term commitment to one of the world’s fastest growing healthcare markets. The new investment will focus on strengthening
Chinese home appliance giant Midea Group has announced plans to invest 60 billion yuan, about 8.7 billion US dollars, in artificial intelligence and robotics over the next three years as it deepens its transition from traditional manufacturing to advanced automation technologies. The company
